Clinuvel Pharmaceuticals stock forecast
Want to see AU:CUV full AI Analyst Report?
Clinuvel Pharmaceuticals (CUV) Share Forecast & Price Target
CUV Analyst Ratings
CUV Stock 12 Month Forecast
Average Price Target
AU$16.35▲(124.28% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Iain Wilkie | Morgans | AU$10→AU$7 | hold | -3.98%Downside | Downgraded | 10/21/26 | ||
| Sarah Mann | MA Financial Group | AU$14.43 | buy | 97.94%Upside | Reiterated | 08/30/26 | ||
| David Stanton | Jefferies | AU$40.80→AU$39.30 | buy | 439.09%Upside | Reiterated | 08/30/26 | ||
| Thomas Wakim | Bell Potter | AU$11.50 | hold | 57.75%Upside | Downgraded | 08/27/26 | ||
| Madeleine Williams | Canaccord Genuity | AU$9.52 | hold | 30.59%Upside | Downgraded | 08/27/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Iain WilkieMorgans | HoldDowngradedAU$10→AU$7 | 10/21/26 | -3.98%Downside | ||
| Sarah MannMA Financial Group | BuyReiteratedAU$14.43 | 08/30/26 | 97.94%Upside | ||
| David StantonJefferies | BuyReiteratedAU$40.80→AU$39.30 | 08/30/26 | 439.09%Upside | ||
| Thomas WakimBell Potter | HoldDowngradedAU$11.50 | 08/27/26 | 57.75%Upside | ||
| Madeleine WilliamsCanaccord Genuity | HoldDowngradedAU$9.52 | 08/27/26 | 30.59%Upside |
Best Analysts Covering Clinuvel Pharmaceuticals
Copying David Stanton's trades and holding each position for 3 Months would result in 27.27% of your transactions generating a profit, with an average return of -9.22% per trade.
Copying David Stanton's trades and holding each position for 1 Year would result in 9.09% of your transactions generating a profit, with an average return of -18.05% per trade.
Copying David Stanton's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -26.23% per trade.
CUV Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 0 |
| Buy | 0 | 1 | 1 | 1 | 0 |
| Hold | 0 | 3 | 3 | 4 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 2 | 6 | 6 | 6 | 1 |
In the current month, CUV has received 0 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. CUV average Analyst price target in the past 3 months is 16.35.
CUV Financial Forecast
CUV Earnings Forecast
Next quarter’s earnings estimate for CUV is AUD 0.25 with a range of AUD 0.19 to AUD 0.35. The previous quarter’s EPS was AUD 0.47. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
CUV Sales Forecast
Next quarter’s sales forecast for CUV is AUD 36.23M with a range of AUD 35.50M to AUD 36.90M. The previous quarter’s sales results were AUD 57.09M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

